Matt Rieke
Directeur/Membre du Conseil chez Bio Ventures for Global Health
Profil
Dr. Matt Rieke, MD MBA, is Partner at Quaker Partners Management LP and an Advisor at Ben Franklin Technology Partners.
He is on the Board of Directors at Neotropix, Inc., Bio Ventures for Global Health, Pennsylvania Biotechnology Association, BioRexis Pharmaceutical Corp., and Tarsa Therapeutics, Inc. He is a Founding Partner of Quaker Partners since 2002.
Dr. Rieke was previously employed as Partner by PA Early Stage Partners.
He also served on the board at NB Therapeutics, Inc., Biolex Therapeutics, Inc., TearScience, Inc., and TransEnterix, Inc.
Dr. Rieke received his B.A.
from Colgate University, Doctor of Medicine from the University of Pennsylvania School of Medicine and an MBA from the Wharton School of the University of Pennsylvania.
Postes actifs de Matt Rieke
| Sociétés | Poste | Début |
|---|---|---|
| Bio Ventures for Global Health | Directeur/Membre du Conseil | - |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Directeur/Membre du Conseil | - |
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matt Rieke
| Sociétés | Poste | Fin |
|---|---|---|
NB Therapeutics
 NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Directeur/Membre du Conseil | - |
Novitas Capital Management LLC
 Novitas Capital Management LLC Investment ManagersFinance Novitas Capital Management (Novitas Capital) is a venture capital firm founded in 1997. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 31/12/2000 |
TransEnterix, Inc. /Old/
 TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology TransEnterix is advancing the field of minimally invasive surgery through exploration, innovation and collaboration. Based in North Carolina's Research Triangle Park, TransEnterix is a rapidly growing medical device company founded in 2006. Since its inception the company has designed, received FDA approval and launched the groundbreaking SPIDER Surgical System, which provides surgeons with enhanced capabilities by creating triangulation via single site access with flexible articulating instruments. The platform enables a whole new class of less invasive surgery - Flexible Laparoscopy - which builds on the proven technologies of laparoscopic surgery and catheter based medical treatments. | Directeur/Membre du Conseil | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
TearScience, Inc.
 TearScience, Inc. Electronic ComponentsElectronic Technology TearScience, Inc. diagnoses and treats meibomian gland dysfunction. It offers Lipiflow, Lipiscan, and Lipiview. The company was founded by Donald R. Korb and Timothy R. Willis in 2005 and is headquartered in Morrisville, NC. | Directeur/Membre du Conseil | - |
Formation de Matt Rieke
| Colgate University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Novitas Capital Management LLC
Novitas Capital Management LLC Investment ManagersFinance Novitas Capital Management (Novitas Capital) is a venture capital firm founded in 1997. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
NB Therapeutics
NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Health Technology |
Neotropix, Inc.
 Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Health Technology |
| Bio Ventures for Global Health | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Distribution Services |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
TearScience, Inc.
TearScience, Inc. Electronic ComponentsElectronic Technology TearScience, Inc. diagnoses and treats meibomian gland dysfunction. It offers Lipiflow, Lipiscan, and Lipiview. The company was founded by Donald R. Korb and Timothy R. Willis in 2005 and is headquartered in Morrisville, NC. | Electronic Technology |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
TransEnterix, Inc. /Old/
TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology TransEnterix is advancing the field of minimally invasive surgery through exploration, innovation and collaboration. Based in North Carolina's Research Triangle Park, TransEnterix is a rapidly growing medical device company founded in 2006. Since its inception the company has designed, received FDA approval and launched the groundbreaking SPIDER Surgical System, which provides surgeons with enhanced capabilities by creating triangulation via single site access with flexible articulating instruments. The platform enables a whole new class of less invasive surgery - Flexible Laparoscopy - which builds on the proven technologies of laparoscopic surgery and catheter based medical treatments. | Health Technology |
